Faculty Founder: Dana Anderson, PhD (Physics)
Focus: Quantum computing and cold atom technology
CEO Scott Faris
Recent Results:
- Launched Hilbert, a cloud-based quantum computer in 2021
- Raised $72 million in funding
Faculty Founders: Sehee Lee, PhD, Conrad Stoldt, PhD (Mechanical Engineering)
Focus: Solid-state electric vehicle batteries with increased range and safety
CEO Doug Campbell
Recent Results:
- Secured $650 million in 2021 investments
- Partnered with major investors including BMW and Ford
Faculty Founder: Eric Keller, PhD (Electrical, Computer & Energy Engineering)
Focus: Network connectivity solutions
CEO & Co-Founder Murad Kablan, PhD
Recent Results:
- Partnered with PacketFabric and Console Connect
- Closed $11.3 million Series A
Faculty Founder: Ryan Gill, PhD (Renewable & Sustainable Energy Institute)
Focus: Digital genome engineering
CEO Sri Kosaraju
Recent Results:
- Launched Onyx genome engineering platform in 2021
- Raised $500 million to date
Faculty Founder: Xuedong Liu, PhD (Biochemistry)
Focus: New treatments for multiple cancer types
CEO & CO-FOUNDER Tony Piscopio, PhD
Recent Results
- Lead product entering Phase II clinical trials, partnered with Pfizer
- Closed $55M Series B in 2021
Faculty Founder: Larry Gold, PhD (Molecular, Cellular & Developmental Biology)
Focus: Health, wellness and disease monitoring through proteomics
CEO Roy Smythe, MD
Recent Results
- Boasts deepest protein analysis available with SomaScan(R) platform
- Raised $630 million in 2021 IPO
Faculty Founders: Ted Randolph, PhD (Chemical & Biological Engineering) Bob Garcea, MD (Molecular, Cellular & Developmental Engineering)
Focus: Single shot, thermostable vaccine formulations
CEO Matthew Raider
Recent Results
- $7 million Series A led by Adjuvant Capital
- Partnered with Forge Nano to combine multiple vaccine doses using atomic layer deposition
Faculty Founders: Linda Watkins, PhD (Psychology & Neuroscience)
Focus: New treatments for osteoarthritis, neuropathic pain and other indications
CEO Diem Nguyen, PhD
Recent Results
- Lead product in Phase II/III clinical trials
- Closed $30 million Series C in 2021